Clinical Trial Update: Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating feasibility and safety of collecting autologous hematopoietic stem cells and combining them with CAR T-cell therapy in relapsed/refra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Diffuse Large B-cell Lymphoma
• Mantle Cell Lymphoma
• Multiple Myeloma

Snippet

Sponsor: Joshua Sasine, MD, PhD | Conditions: Hematologic Malignancy, Large B-cell Lymphoma | Phase 1 | Status: RECRUITING